Month: September 2024

AITX’s RAD Kicks Off Q3 FY 2025 with Strong Opening Order, Accelerated Dealer Growth, and Strong Order Momentum

Written by Customer Service on September 4, 2024. Posted in Public Companies.

Multi-Unit Reorder to Start New Quarter & 2nd Half of Fiscal Year Detroit, Michigan, Sept. 04, 2024 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCPK:AITX), a global leader in AI-driven security and productivity solutions, along with its wholly-owned subsidiary Robotic Assistance Devices, Inc. (RAD), is pleased to announce a strong start to Q3 of FY 2025, marked by the first day of quarter achieving multi-unit new device order intake as well as multi-device unit deployment at an existing big-box retail client. The Company is capitalizing on its successful Q2 FY 2025, which ended August 31, 2024, with a record-breaking 172 units ordered, as RAD continues to accelerate its growth trajectory into the second half of its fiscal year. The multi-unit order is the fourth order...

Collegium Completes Acquisition of Ironshore Therapeutics

Written by Customer Service on September 4, 2024. Posted in Mergers And Acquisitions.

– Adds Commercial Product Jornay PM®, Establishing Collegium’s Presence in Neurology (ADHD) – – Collegium Updates 2024 Financial Guidance to Reflect Expected Immediate Accretion from the Ironshore Acquisition – – 2024 Product Revenues, Net Expected in the Range of $620.0 Million to $635.0 Million – STOUGHTON, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it has completed the acquisition of Ironshore Therapeutics Inc., a privately held company that markets and distributes Jornay PM (methylphenidate HCl), a central nervous system (CNS) stimulant for the treatment of attention deficit hyperactivity disorder (ADHD). Collegium also updated...

Satellite Communication (SATCOM) Market to Gain USD 188.94 Billion by 2031 | SkyQuest Technology

Written by Customer Service on September 4, 2024. Posted in Mergers And Acquisitions.

Westford, USA, Sept. 04, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Global Satellite Communication (SATCOM) Market will attain a value of USD 188.94 Billion by 2031, with a CAGR of 9.60% during the forecast period (2024-2031). This expectation is made possible by High-throughput Satellite (HTS) systems, which have considerably faster data transfer speeds and larger capacity than conventional systems; thus, they will entrench themselves so well within the market such that they are likely to evolve fast due to market demand trends. HTS systems enable quicker and more efficient data transfers for applications that require a lot of bandwidth, including video streaming services, remote sensing technologies and IoT connections. Such frequency bands include low frequencies and high frequencies, which are the new kids on the block...

A New Era in Publisher Monetization: Aditude Acquires Category Leader Hashtag Labs

Written by Customer Service on September 4, 2024. Posted in Mergers And Acquisitions.

NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) — Aditude, a leading programmatic advertising platform, announced its acquisition of Hashtag Labs (HTL), a renowned provider of enterprise-level UI and automation systems for publishers. This strategic move signals a significant shift in the digital publishing and advertising landscape as both companies join forces to empower publishers with cutting-edge tools and more efficient business models. By combining Aditude’s scalable SaaS solutions with HTL’s comprehensive ad tech control system, publishers can now access an unparalleled platform that maximizes revenue while offering complete control over their monetization strategies. This partnership is not just a competitive advantage—it is necessary for the future of publishing, ensuring that publishers retain more revenue during these transformative...

Cross Keys Capital Advises Illinois CancerCare in Its Strategic Relationship with The US Oncology Network

Written by Customer Service on September 4, 2024. Posted in Mergers And Acquisitions.

Fort Lauderdale, Sept. 04, 2024 (GLOBE NEWSWIRE) — Cross Keys Capital, a leading independent investment banking firm providing M&A advisory services to physician group practices and healthcare services companies, is pleased to announce it acted as the exclusive financial advisor to Illinois CancerCare (ILCC) in its strategic relationship with The US Oncology Network (The Network). ILCC has 14 sites of service located throughout the Central Illinois market. ILCC’s 21 physicians and 37 advanced practice providers offer medical oncology and hematology care in addition to a variety of ancillary services including specialty retail pharmacy, genetic testing, imaging, research, and clinical trials. ILCC is the largest independent oncology practice in the Midwest United States and is led by its President, Paul Fishkin, MD, and Executive...

GDEV announces unaudited results for the second quarter and first half of 2024

Written by Customer Service on September 4, 2024. Posted in Earnings Releases And Operating Results.

LIMASSOL, Cyprus, Sept. 04, 2024 (GLOBE NEWSWIRE) — GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company (“GDEV” or the “Company”) released its unaudited financial and operational results for the second quarter and first half-year ended June 30, 2024. GDEV CEO, Andrey Fadeev stated: “Over the past months, we’ve been refining our strategic vision, and now we’re prepared to push forward with renewed confidence. Despite the temporary decline in some of our key operational and financial metrics, our ability to maintain a robust revenue mix between PC and mobile platforms — where PC has grown to 42% of our total bookings — underscores our adaptive strategy and resilience. Additionally, our strong cash flow trends, the significant reduction in platform commissions and the reduction of the game operation...

The Saudi Food and Drug Authority (SFDA) Approves Biomerica’s At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

Written by Customer Service on September 4, 2024. Posted in Public Companies.

– 10-Minute At-Home PSA Test for Early Detection of Prostate Cancer – First order already shipped to Saudi Arabia – Prostate Cancer is the Second Most Common Cancer in Men Globally IRVINE, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA) is pleased to announce that the Saudi Food and Drug Authority (SFDA) has approved the Company’s Fortel® Prostate (PSA) Screening Test to be sold and used in the country. This at-home test is designed to empower men with the ability to detect early warning signs of prostate cancer from the comfort of their own homes. The Fortel® Prostate (PSA) At-Home Screening Test is a user-friendly, rapid diagnostic tool that measures elevated PSA, an early indicator of prostate disease, including cancer. Utilizing a simple finger-prick blood sample, the test delivers...

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Written by Customer Service on September 4, 2024. Posted in Public Companies.

SCOTTSDALE, Ariz., Sept. 04, 2024 (GLOBE NEWSWIRE) — Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 26th Annual Global Investment Conference. The presentation will be available for on-demand viewing by conference attendees starting on September 9, 2024, at 7:00 a.m. ET. The Company will also attend one-on-one meetings during the conference. A replay of the presentation will be available shortly after the conference on the News and Events...

America’s Car-Mart Reports First Quarter Fiscal Year 2025 Results

Written by Customer Service on September 4, 2024. Posted in Earnings Releases And Operating Results.

ROGERS, Ark., Sept. 04, 2024 (GLOBE NEWSWIRE) — America’s Car-Mart, Inc. (NASDAQ: CRMT) (“we,” “Car-Mart” or the “Company”), today reported financial results for the first quarter ended July 31, 2024. First Quarter Key Highlights (FY’25 vs. FY’24 Q1, unless otherwise noted)Revenue was $347.8 million, down 5.2% Interest income increased $4.1 million, up 7.2% Total collections increased 4.3% to $172.9 million Favorable adjustment to allowance for credit loss to 25.0%, down from 25.32% Net charge-offs as a % of average finance receivables were 6.4% vs. 5.8% Interest expense increased $4.0 million, or 28.3% Loss per share of $0.15 vs. diluted earnings per share of $0.63President and CEO Doug Campbell commentary: “I’m encouraged with our rebound in sales volume from two quarters ago, despite the ongoing economic challenges...

Daktronics, Inc. Announces 2025 Fiscal First Quarter Results

Written by Customer Service on September 4, 2024. Posted in Earnings Releases And Operating Results.

Solid Sequential GAAP Revenue Growth, Margin Expansion, and Cash Flow Generation Earned $22.7 Million of Operating Income and Adjusted Net Income(1) of $16.6 Million BROOKINGS, S.D., Sept. 04, 2024 (GLOBE NEWSWIRE) — Daktronics, Inc. (NASDAQ-DAKT), the leading U.S.-based designer and manufacturer of best-in-class dynamic video communication displays and control systems for customers worldwide, today reported results for its fiscal 2025 first quarter which ended July 27, 2024. Fiscal Q1 2025 financial highlights:Sales of $226.1 million, a 4.7 percent sequential increase from the fourth quarter of fiscal 2024, aligning with expected seasonal demand and driven by increased production and deliveries for sports and outdoor related seasonal business Gross profit as a percentage of net sales of 26.4 percent as compared to 25.7 percent...

Month: September 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals